TNF and infection: The antigens targeted by mAb therapeutics where infections have been side effects include: TNF, TNFSF13B, VEGFA, TNFRSF8, ILIB, CD80-CD86, TNSF11, C5, PCSK9, Dabigatran etexilate mesylate, IL5, ITGA4, MS4A1, IGHE, anthrax protective antigen, MPL, IL6, IL6R, EI, and ITGB7.